Tinavi Medical Technologies Co.,Ltd. (SHA:688277)
18.42
+0.01 (0.05%)
Aug 15, 2025, 3:00 PM CST
SHA:688277 Revenue
Tinavi Medical Technologies had revenue of 58.58M CNY in the quarter ending March 31, 2025, with 102.40% growth. This brings the company's revenue in the last twelve months to 208.48M, up 4.51% year-over-year. In the year 2024, Tinavi Medical Technologies had annual revenue of 178.84M, down -14.85%.
Revenue (ttm)
208.48M
Revenue Growth
+4.51%
P/S Ratio
39.99
Revenue / Employee
679.09K
Employees
307
Market Cap
8.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 178.84M | -31.19M | -14.85% |
Dec 31, 2023 | 210.04M | 53.85M | 34.48% |
Dec 31, 2022 | 156.19M | 166.52K | 0.11% |
Dec 31, 2021 | 156.02M | 20.11M | 14.80% |
Dec 31, 2020 | 135.91M | -93.65M | -40.80% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
WuXi AppTec | 41.48B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |